#Candidaauris

A drug-resistant fungus, Candida auris, is prompting renewed warnings from global health authorities. A U.S. hospital study shows the pathogen, first identified in 2016, has spread within healthcare settings and is proving difficult to treat with standard antifungal drugs. The spread is most evident in Georgia and within Miami’s hospital network, where vulnerable patients with medical devices face heightened risk.

Candida auris presents a major treatment challenge because many antifungal medications are ineffective against it. A health expert notes that patients with weakened immune systems may rely on their own defenses when therapies fail, underscoring the stakes for high-risk groups.